CIK 0001253689
- Non-accelerated filer
- Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- Operating
- Phone
- +1 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 4 Exercise or conversion Director acquired 21,000 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale SVP Finance, CFO sold 3,700 shares at $1.95 ($7,215)
- 4 Open-market buy Director bought 30,000 shares at $1.56 ($46,800)
- 4 Open-market buy SVP & Chief Commercial Officer bought 13,500 shares at $1.57 ($21,195)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy 10% owner bought 100,000 shares at $1.70 ($170,000)
- 4 Open-market buy 10% owner bought 400,000 shares at an average $1.78 ($712,255)
- 4 Open-market buy 10% owner bought 1,515,266 shares at an average $2.00 ($3,027,929)
- 4 Open-market buy 10% owner bought 11,451 shares at $3.24 ($37,123)
- 3 Insider Initial Statement of Ownership
- 5 Insider Annual Insider Trading Report
- 4 Exercise or conversion Director acquired 10,500 shares (option exercise)
Page 5 of 15 · 293 filings